Development of a Humanized Mouse Model for Sjögren's Syndrome

A 2026 study by Jin-Sil Park describes a preclinical humanized mouse model developed to represent Sjögren's syndrome. The model uses PBMCs from SS patients transplanted into NSG mice and was tested with metformin treatment. The dataset likely contains detailed methodological and results data from this biomedical research.

Use Cases

• Evaluating therapeutic efficacy based on metformin treatment results described in the study
• Analyzing immune cell infiltration patterns based on histopathological analysis of salivary glands
• Studying pathogenic T cell recruitment based on the association with CXCR3+ Th17 cells
• Investigating disease mechanisms based on the reproduction of key cellular and molecular features of SS

Strengths

• The dataset is associated with a specific, peer-reviewed research study with a clear methodology.
• Results include concrete measurements such as frequency of IL-17-producing T cells and Aquaporin-5 expression reduction.
• The model was validated for investigating early-stage disease mechanisms and evaluating novel therapies.

Limitations

• The dataset is a 16.5 KB DOCX file, suggesting limited scope and likely containing summary text rather than raw experimental data.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for quantitative analysis.

Provenance

Source

Jin-Sil Park via figshare.

Collection Method

Likely contains data generated from a laboratory study involving PBMC transplantation into NSG mice and subsequent analysis.

Freshness

Last updated 2026-05-22 05:34:48; freshness should be verified.